NEU neuren pharmaceuticals limited

Ann: DAYBUE (trofinetide) 2024 net sales US$348 million, page-27

  1. 7,028 Posts.
    lightbulb Created with Sketch. 757
    They are too far behind now. But if they'd accelerated 2 years ago they could have beaten us to the PRV. (if it gets awarded).

    And as someone said the other day, maybe they are just letting NEU do the heavy lifting on NNZ2591 and might use it later.

    I'm guessing that all they care about right now is the EU.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.85
Change
-0.110(0.85%)
Mkt cap ! $1.598B
Open High Low Value Volume
$12.82 $13.05 $12.53 $6.559M 511.8K

Buyers (Bids)

No. Vol. Price($)
1 1657 $12.83
 

Sellers (Offers)

Price($) Vol. No.
$12.85 6303 1
View Market Depth
Last trade - 16.10pm 17/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.